![]() BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. | Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | |
Founding Date | Founding Date 1986 | Founding Date 1975 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Durham, US HQ Hoover, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES |
Employees | Employees 14040% increase | Employees 332 |
Financial | ||
Revenue (est.) | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $346.7m (FY, 2018) |
Cost of goods | Cost of goods $19.1m (FY, 2025) | Cost of goods $190.3m (FY, 2018) |
Gross profit | Gross profit $855.8m (FY, 2025) | Gross profit $156.4m (FY, 2018) |
Net income | Net income $263.9m (FY, 2025) | Net income $40.5m (FY, 2018) |
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View company